These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39205940)

  • 1. Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML).
    Wen S; Lv X; Ma X; Deng S; Xie J; Yuan E
    Front Genet; 2024; 15():1419819. PubMed ID: 39205940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
    Chen L; Lin J; Wen Y; Chen Y; Chen CB
    Front Oncol; 2023; 13():1291720. PubMed ID: 38023241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy.
    Wan P; Zhong L; Yu L; Shen C; Shao X; Chen S; Zhou Z; Wang M; Zhang H; Liu B
    Front Immunol; 2024; 15():1384633. PubMed ID: 38799454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death.
    Sheng X; Lu J; Wang J; Fan K; Huang M; Lu Q
    Expert Rev Hematol; 2023; 16(7):543-551. PubMed ID: 37114857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas.
    Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429083
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.
    Chen Y; Qiu X; Liu R
    BMC Med Genomics; 2024 Apr; 17(1):107. PubMed ID: 38671491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs.
    He M; Gu W; Gao Y; Liu Y; Liu J; Li Z
    Front Immunol; 2022; 13():1043827. PubMed ID: 36479122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.
    Yao Y; Zhang Q; Wei S; Li H; Zhou T; Zhang Q; Zhang J; Zhang J; Wang H
    Transl Cancer Res; 2024 Jun; 13(6):2913-2937. PubMed ID: 38988945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
    Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia.
    Zhong F; He S; Guo N; Shi L; Zhang L; Jin H; Kong G
    Cancer Cell Int; 2024 Apr; 24(1):139. PubMed ID: 38627685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma.
    Zeng H; Jiang Q; Zhang R; Zhuang Z; Wu J; Li Y; Fang Y
    Sci Rep; 2024 Oct; 14(1):22872. PubMed ID: 39358546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
    Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
    Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
    [No Abstract]   [Full Text] [Related]  

  • 17. A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma.
    Dong P; Zhao L; Zhao L; Zhang J; Lu G; Zhang H; Ma M
    Transl Cancer Res; 2024 Jan; 13(1):249-267. PubMed ID: 38410237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing.
    Zhong F; Jiang J; Yao FY; Liu J; Shuai X; Wang XL; Huang B; Wang X
    Front Pharmacol; 2023; 14():1272701. PubMed ID: 38053840
    [No Abstract]   [Full Text] [Related]  

  • 20. A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer.
    Song Q; Zhou Z; Bai J; Liu N
    Clin Transl Oncol; 2023 Aug; 25(8):2587-2606. PubMed ID: 37000291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.